Affective disorders and norepinephrine pharmacology.
D000818:Animals; D001519:Behavior / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D002746:Chlorpromazine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003042:Cocaine / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000378:metabolism*; D004644:Emotions / Q000187:drug effects; D005260:Female; D006801:Humans; D007036:Hypothermia, Induced; D007099:Imipramine / Q000494:pharmacology / Q000627:therapeutic use; D008094:Lithium / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism* / Q000652:urine; D009647:Normetanephrine / Q000652:urine; D010919:Placebos; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013747:Tetrabenazine / Q000494:pharmacology; D014642:Vanilmandelic Acid / Q000652:urine
D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D009647:Normetanephrine; D014642:Vanilmandelic Acid; D012110:Reserpine; D008094:Lithium; D003042:Cocaine; D007099:Imipramine; D002746:Chlorpromazine; D009638:Norepinephrine; D013747:Tetrabenazine